News Ex-Allergan CEO Saunders pops up again in ‘blank cheque’ com... Brent Saunders has been out of the limelight for a few months since departing Allerg
Oncology Treating primary bone cancer: The potential of listeria-base... In a new pharmaphorum podcast, Paul Romness, president and CEO of OS Therapies, discusses the company's work in osteosarcoma.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
